Our Blog | Biosimilars & Generics | AAM

Generic Prescription Drugs - Your Health. Our Commitment. #Take with Confidence

May 29, 2019 | Erica Klinger

Five Lessons from a National Collaboration to Promote Prescription Drug Safety

May 28, 2019 | Jewel Smith

Join AAM Today!

May 23, 2019 | Erica Klinger

WiHP Event Features Congressional Speaker

AAM Capitol Hill May 10 Briefing on NAFTA 2.0 with Representative Earl Blumenauer

May 13, 2019 | Erica Klinger

Highlights from the NAFTA 2.0 Congressional Briefing: The May 10 Amendments

May 9, 2019 | AAM

2019 Generic Drug and Biosimilars Access & Savings in the U.S. Report

Apr 25, 2019 | Allen Goldberg

National Drug Take Back Day Is Saturday: Here’s What You Need to Know

Jonnie is Informed about Generic Prescriptions. How Does Your Knowledge Measure Up?

Apr 23, 2019 | Erica Klinger

Jonnie Is Informed about Generic Prescriptions. How Does Your Knowledge Measure Up?

Trade Agreement: 3 Obstacles to More Affordable Medicines in the U.S.

Apr 1, 2019 | Jonathan Kimball

NAFTA 2.0: 3 Obstacles to More Affordable Medicines in the U.S.

Mar 28, 2019 | Erica Klinger

AAM Wins Bronze Award from Association TRENDS

Healthcare Leadership Luncheon sponsored by Mylan N.V. and powered by Women in Health Policy (WiHP)

Mar 11, 2019 | Anna McDermott-Vitak

Talking Female Leadership at Access! 2019

Feb 26, 2019 | Erica Klinger

Rich’s Generic Story: No Sweat

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars

Feb 20, 2019 | Craig Burton

HHS Proposal Will Help America’s Patients Realize the Full Value of Their Generics and Biosimilars